Labcorp Holdings Inc. (LH)
NYSE • Healthcare
Last close at October 2, 2026 at 20:00 UTC
Metrics Over Time
Where the Money Goes
Q2 2026In plain terms: out of every $100 in revenue, Labcorp Holdings Inc. keeps $8 as net profit.
Fundamentals & Financials
TTM is calculated as the sum of the four most recently completed quarters. This is a standard approach when monthly or real-time data is not available.
Income Statement
Balance Sheet
Financial Highlights
Dividends History
Split History
Earnings
Oct 28
in 24 daysQ4 2026% — EPS deviation from the forecast (beat / miss); quarters without a forecast show the reported EPS
Labcorp Holdings beat expectations on both the top and bottom line in the second fiscal quarter of 2026, reported July 30, based on preliminary results. Revenue rose about 6% to about $3.7 billion from $3.53 billion a year ago, with the U.S., the largest segment, contributing about $2.9 billion and growing about 4%; revenue of about $3.7 billion also edged the $3.71 billion consensus by about 1%. Adjusted EPS was $4.99, topping the $4.78 estimate by about 4% and up about 15% from $4.35 a year ago, while net income increased about 26% to about $299 million from $237.9 million. Gross margin held near 32% and operating margin near 12% as gross profit came in at about $1.2 billion and operating income at about $445 million. Operating cash flow was about $445.5 million, the company repurchased about $353.8 million of stock, and it paid about $58.7 million in dividends. For the next period, consensus calls for EPS of $4.59 on revenue of $3.75 billion.
Next report — what to expect
Labcorp Holdings Inc. (LH) is set to report on October 27, 2026. Wall Street is looking for consensus EPS of $4.65 on consensus revenue of $3.76 billion. For trailing context, revenue grew +5.8% year over year last quarter. LH has beaten EPS in 8 of 8 most recent quarters.
About Labcorp Holdings Inc.
Labcorp Holdings Inc. provides diagnostic laboratory services through a healthcare business centered on medical testing and related research support, and its shares trade on the NYSE under the ticker LH. In FY2025, the company generated $14.0 billion in revenue in the Medical - Diagnostics & Research field.
Today's Snapshot
LH closed 1.3% higher at 308.56, while its sector was flat. Shares changed hands at about half of its usual level.
Trading Volume
Below 10d avg (797.2K)
454.7K
vs S&P 500 Today
Outperforming Market
+0.52%
Updated: October 2, 2026 at 20:07 UTC
Technical Indicators
All signalsHide signals
- EMA (5 indicators)$288.01 - $313.85Sell
- RSI (14)42.77Neutral
- Stochastic %K (14, 3, 3)16.30Buy
- MACD Level (12, 26)-3.64Sell
Peers & Related Assets
Get premium market insights delivered directly to your inbox.